XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Collaboration revenue $ 5,573 $ 11 $ 11,893 $ 32
Operating expenses:        
Research and development 50,639 35,275 127,676 94,645
General and administrative 14,573 10,124 42,158 26,214
Total operating expenses 65,212 45,399 169,834 120,859
Other income (expense):        
Interest income 708 15 1,017 36
Interest expense (880) (98) (2,364) (286)
Total other income (expense), net (172) (83) (1,347) (250)
Net loss (59,811) (45,471) (159,288) (121,077)
Unrealized loss on marketable securities (105) 0 (231) 0
Comprehensive loss (59,916) (45,471) (159,519) (121,077)
Net loss attributable to common stockholders — basic (59,811) (45,471) (159,288) (121,077)
Net loss attributable to common stockholders — diluted $ (59,811) $ (45,471) $ (159,288) $ (121,077)
Net loss per share attributable to common stockholders — basic (in dollars per share) $ (0.61) $ (0.63) $ (1.75) $ (1.73)
Net loss per share attributable to common stockholders — diluted (in dollars per share) $ (0.61) $ (0.63) $ (1.75) $ (1.73)
Weighted-average number of shares of common stock used in net loss per share attributable to common stockholders — basic (in shares) 97,641,936 71,753,004 91,173,989 70,129,236
Weighted-average number of shares of common stock used in net loss per share attributable to common stockholders — diluted (in shares) 97,641,936 71,753,004 91,173,989 70,129,236